Women's Health News

RSS

bioTheranostics reports new findings from study evaluating Breast Cancer Index molecular oncology test

bioTheranostics, a bioMerieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today new findings from a clinical study evaluating the company's Breast Cancer Index (BCI) molecular oncology test. Data from the study were presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

13 Dec 2010

GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

Results of the GeparQuinto study, randomized Phase III efficacy data on the use of bevacizumab plus chemotherapy to treat women with early breast cancer will be presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium.

13 Dec 2010

Syndax reports promising results from entinostat preclinical studies in breast cancer

Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces results from two preclinical studies on entinostat, an orally bioavailable, highly selective, class I histone deacetylase (HDAC) inhibitor, in animal models of breast cancer. The data are being presented as oral poster discussions at the San Antonio Breast Cancer Symposium December 8 through December 12 in San Antonio Texas.

13 Dec 2010

Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer.

13 Dec 2010

Combination of SPECT and CT scans could offer protection against lymphedema in breast cancer patients

With guidance from a specialized scan, radiation oncologists at Mayo Clinic were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses.

13 Dec 2010

Do not delay breast cancer therapy during pregnancy

Do not delay treatment of breast cancer just because a woman is pregnant, said lead researcher Sibylle Loibl, Dr. med, of the German Breast Group.

13 Dec 2010

First-ever Prophylactic Cancer Vaccine Conference to be held in Tempe, Arizona

World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.

13 Dec 2010

Presence of circulating tumor cells in early-stage breast cancer doubles risk of relapse and death

The presence of one to four circulating tumor cells (CTCs) in the blood of early-stage breast cancer patients almost doubled patient's risk of cancer relapse and death, and five or more CTCs increased recurrence by 400 percent and death by 300 percent, according to Phase III results of the SUCCESS trial. These cells were found in patients after surgery but before chemotherapy treatment.

13 Dec 2010

Higher co-payments lead to early discontinuation of life-saving therapy for breast cancer

A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early stage breast cancer.

13 Dec 2010

Researchers conduct trial to study obesity-related respiratory limitations on weight loss

Tamara Ritchie lost 25 pounds in 12 weeks without breaking a sweat. She was just following doctors' orders.

13 Dec 2010

Xeloda may reduce recurrence of faster growing breast cancers: Study

Joyce O'Shaughnessy, M.D., medical director and co-chair of the Breast Cancer Research Committee, US Oncology Research, and medical oncologist with Texas Oncology-Baylor Sammons Cancer Center, presented her study findings today at the 33rd Annual San Antonio Breast Cancer Symposium (SABCS), an international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer

13 Dec 2010

Simple fingertip test may help evaluate risk for CTS in breast cancer patients

A gene target for drug resistance, a triple-drug cocktail for triple negative breast cancer, and patients' risk for carpal tunnel syndrome are among study highlights scheduled to be presented by Johns Hopkins Kimmel Cancer Center scientists during the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12. The information is embargoed for the time of presentation at the symposium.

13 Dec 2010

Combination therapy improves tumor response in HER2-positive breast cancer patients

A combination of lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates than either agent alone among patients with HER2-positive breast cancers, according to data presented at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12.

13 Dec 2010

More sensitive screening tests needed to reduce ovarian cancer deaths

The best currently available screening tests can only slightly reduce ovarian cancer deaths. That is the conclusion of new research published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The results suggest that strategies other than screening, such as prevention and better treatments, will be needed to significantly lower the number of women who die from ovarian cancer.

13 Dec 2010

Novelos NOV-002 demonstrates positive results in Phase 2 neoadjuvant breast cancer trial

Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer, announced that today a poster highlighting positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer is being presented by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine at the AACR Breast Cancer Symposium in San Antonio, TX.

13 Dec 2010

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to researchers from the University of Texas MD Anderson Cancer Center.

13 Dec 2010

Research identifies two genetic variants that increase risk of endometriosis

Research published today identifies two genetic variants that increase the risk of developing endometriosis, a common gynaecological disease. The study provides clues to the origin of this often very painful condition, which has a significant impact on the quality of life of sufferers.

13 Dec 2010

Better approaches to ovarian cancer screening could lower cancer deaths

Cancer prevention experts have long been frustrated by the lack of a meaningful way to screen women for ovarian cancer. It is a relatively rare disease that often progresses with few symptoms until it is too late for potentially curative treatments, and elevated values of the most commonly used biomarker used in screening, CA125, are also related to other disorders.

13 Dec 2010

HOXB7 gene raises tamoxifen resistance in women with early-stage breast cancer

13 Dec 2010

Cesarean-section deliveries may lead to degenerative back disease

Researchers from Michigan State University are studying whether pregnancies, specifically cesarean-section deliveries, are linked to a degenerative back disease that affects women three to nine times more often than men.

13 Dec 2010

Women's Health News

bioTheranostics reports new findings from study evaluating Breast Cancer Index molecular oncology test

GeparQuinto study data on bevacizumab plus chemotherapy in early breast cancer to be presented at 33rd CTRC-AACR

Syndax reports promising results from entinostat preclinical studies in breast cancer

Exemestane may provide post-surgery option for postmenopausal women with hormone-receptor positive breast cancer

Combination of SPECT and CT scans could offer protection against lymphedema in breast cancer patients

Do not delay breast cancer therapy during pregnancy

First-ever Prophylactic Cancer Vaccine Conference to be held in Tempe, Arizona

Presence of circulating tumor cells in early-stage breast cancer doubles risk of relapse and death

Higher co-payments lead to early discontinuation of life-saving therapy for breast cancer

Researchers conduct trial to study obesity-related respiratory limitations on weight loss

Xeloda may reduce recurrence of faster growing breast cancers: Study

Simple fingertip test may help evaluate risk for CTS in breast cancer patients

Combination therapy improves tumor response in HER2-positive breast cancer patients

More sensitive screening tests needed to reduce ovarian cancer deaths

Novelos NOV-002 demonstrates positive results in Phase 2 neoadjuvant breast cancer trial

CTCs in metastatic breast cancer patients linked to cancer recurrence, poor survival rates

Research identifies two genetic variants that increase risk of endometriosis

Better approaches to ovarian cancer screening could lower cancer deaths

HOXB7 gene raises tamoxifen resistance in women with early-stage breast cancer

Cesarean-section deliveries may lead to degenerative back disease

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News